The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 15, 2024

Filed:

Jan. 11, 2022
Applicant:

The University of Queensland, St Lucia, AU;

Inventors:

Keith Joseph Chappell, St Lucia, AU;

Daniel Watterson, St Lucia, AU;

Paul Robert Young, St Lucia, AU;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/02 (2006.01); C07K 14/16 (2006.01); C07K 19/00 (2006.01); C12N 15/10 (2006.01);
U.S. Cl.
CPC ...
C07K 14/16 (2013.01); C07K 19/00 (2013.01); C12N 15/1034 (2013.01); C07K 2317/55 (2013.01); C07K 2319/35 (2013.01); C12N 2740/16122 (2013.01); C12N 2740/16134 (2013.01); C12N 2760/10022 (2013.01); C12N 2760/10034 (2013.01); C12N 2760/14022 (2013.01); C12N 2760/14034 (2013.01); C12N 2760/16122 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/18022 (2013.01); C12N 2760/18034 (2013.01); C12N 2770/20022 (2013.01); C12N 2770/20034 (2013.01);
Abstract

Disclosed are chimeric polypeptides based on viral membrane fusion proteins. More particularly, the present invention discloses chimeric polypeptides that comprise a virion surface exposed portion of a viral fusion protein and a heterologous structure-stabilizing moiety, and to complexes of those chimeric polypeptides. The present invention also discloses the use of these complexes in compositions and methods for eliciting an immune response to a fusion protein of an enveloped virus, or complex of the fusion protein, and/or for treating or preventing an enveloped virus infection. The present invention further discloses the use of the heterologous structure-stabilizing moiety for oligomerizing heterologous molecules of interest.


Find Patent Forward Citations

Loading…